A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
7 Hills Pharma, LLC
7 Hills Pharma, LLC
Filamon LTD
Elephas
Novartis
Elephas
OncoNano Medicine, Inc.
Massive Bio, Inc.
Delfi Diagnostics Inc.
Medicenna Therapeutics, Inc.
DEKA Biosciences
Tempus AI
Turnstone Biologics, Corp.
Revolution Medicines, Inc.
Checkpoint Therapeutics, Inc.
Taproot Health
VitaMed Research LLC
Sanguine Biosciences
Klus Pharma Inc.
Revolution Medicines, Inc.
Bristol-Myers Squibb
Revolution Medicines, Inc.
Allarity Therapeutics
BioNTech SE
SpeciCare
Lumos Pharma
Celgene
Santa Maria Biotherapeutics
BIND Therapeutics
Calando Pharmaceuticals
NS Pharma, Inc.